UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _ to _ Commission File Number 001-37587 CytomX Therapeutics, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 27-3521219 (State or oth ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36829 Rocket Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdicti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ COMMISSION FILE NUMBER 000-51122 EyePoint Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other ju ...

Exhibit 99.1 Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates CAMBRIDGE, Mass., Nov. 6, 2025 – Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today provided an update on the MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nexiguran ziclumeran (nex-z) and reported other business updates and financial results for the third quarter ended September 30, 2025. "We ...

Exhibit 99.1 www.brileysecurities.com ARLINGTON, VA, November 6, 2025 – B. Riley Securities Holdings, Inc. ("B. Riley Securities," "BRS" or the "Company"), a leading middle market investment bank, today provided a business update and certain preliminary financial results for the three-month period ended September 30, 2025. Financial Highlights Management Commentary "B. Riley Securities delivered a highly profitable third quarter, building on our second quarter momentum, with significant client engagement ac ...

Exhibit 99.1 www.brileysecurities.com B. Riley Securities Releases Third Quarter 2025 Business Update and Financial Highlights ARLINGTON, VA, November 6, 2025 – B. Riley Securities Holdings, Inc. ("B. Riley Securities," "BRS" or the "Company"), a leading middle market investment bank, today provided a business update and certain preliminary financial results for the three-month period ended September 30, 2025. Financial Highlights Management Commentary "B. Riley Securities delivered a highly profitable thir ...

Exhibit 99.1 www.brileysecurities.com B. Riley Securities Releases Third Quarter 2025 Business Update and Financial Highlights ARLINGTON, VA, November 6, 2025 – B. Riley Securities Holdings, Inc. ("B. Riley Securities," "BRS" or the "Company"), a leading middle market investment bank, today provided a business update and certain preliminary financial results for the three-month period ended September 30, 2025. Financial Highlights Management Commentary "B. Riley Securities delivered a highly profitable thir ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 b For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37869 Cars.com Inc. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identificatio ...

Exhibit 99.1 HireQuest Reports Financial Results for Third Quarter 2025 GOOSE CREEK, South Carolina – November 6, 2025 – HireQuest, Inc. (Nasdaq: HQI), a national franchisor of on-demand staffing and executive search services, today reported financial results for the third quarter ended September 30, 2025. Rick Hermanns, HireQuest's President and Chief Executive Officer, commented, "The U.S. staffing industry continued to contend with a muted hiring landscape in the third quarter, as employers maintained a ...

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, November 6, 2025 (GLOBENEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2025. Summary Financial Results | ($ in millions, except | | | Three Months | | | | Nine Months | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | ...